AudreyMSigmundMD(She/Her)

PubMed

• A cancer disparities curriculum in a hematology/oncology fellowship program.
  Marium Husain, Muhammad Salman Faisal, Dionisia Quiroga, Audrey M Sigmund, Gregory Otterson, Alison Walker, Samilia Obeng-Gyasi, Beth Christian> ;BMC Medical Education. 2023 Oct 17
• Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.
  Ansel Nalin, Qiuhong Zhao, Timothy Voorhees, David Bond, Yazeed Sawalha, Walter Hanel, Audrey Sigmund, Kaitlin Annunzio, Lapo Alinari, Robert Baiocchi, Kami Maddocks, ...> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience.
  Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, Patrick Elder, Don M Benson, Sumithira Vasu, Samantha Jaglowski, Alice Mims, Hannah Choe, Karilyn Larkin, Jonathan E Bram...> ;Cancers. 2022 Nov 14
• 10 citations
  Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
  Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
• 6 citations
  Richter's Transformation.
  Audrey M Sigmund, Adam S Kittai> ;Current Oncology Reports. 2022 Aug 1
• 3 citations
  Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib.
  Audrey M Sigmund, Ying Huang, Amy S Ruppert, Kami Maddocks, Kerry A Rogers, Samantha Jaglowski, Seema A Bhat, Adam S Kittai, Michael R Grever, John C Byrd, Jennifer A ...> ;Leukemia. 2022 Aug 1
• 3 citations
  Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.
  Audrey M Sigmund, Nathan Denlinger, Ying Huang, David Bond, Timothy Voorhees, Amneet Bajwa, Patrick Elder, Jonathan E Brammer, Ayman Saad, Sam Penza, Sumithira Vasu, M...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• 5 citations
  Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
  Malika Kapadia, Leslie Lehmann, Jeffery Auletta, Lisa Beatty, Neel Bhatt, Robyn Blacken, Kathy Demmel, Therese Dodd, Catherine Desmond, Taylor Fitch, Laura Flesch, Dav...> ;Transplantation and Cellular Therapy. 2022 May 1
• 5 citations
  Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.
  Audrey M Sigmund, Qiuhong Zhao, Justin Jiang, Patrick Elder, Don M Benson, Ashley Rosko, Naresh Bumma, Abdullah Khan, Srinivas Devarakonda, Sumithira Vasu, Samantha Ja...> ;Frontiers in Oncology. 2022 Jan 1
• 2 citations
  Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
  Nidhi Sharma, Muhammad Salman Faisal, Qiuhong Zhao, Justin Jiang, Patrick Elder, Don M. Benson, Ashley E. Rosko, Maria Chaudhry, Naresh Bumma, Abdullah Khan, Srinivas ...> ;Journal of Clinical Medicine. 2021 Jun 27
• 8 citations
  Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy.
  Audrey M. Sigmund, Kieran D Sahasrabudhe, Bhavana Bhatnagar> ;Blood and Lymphatic Cancer. 2020 Nov 3
• 26 citations
  AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances.
  Kristin L. Koenig, Kieran D Sahasrabudhe, Audrey M. Sigmund, Bhavana Bhatnagar> ;Genes. 2020 Jul 24
• 59 citations
  Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.
  Kerry A. Rogers, Luay Mousa, Qiuhong Zhao, Seema A. Bhat, John C. Byrd, Zeinab El Boghdadly, Tomas Guerrero, Lauren B. Levine, Fabienne Lucas, Polina Shindiapina, Audr...> ;Leukemia. 2019 May 13
• Join now to see all

Journal Articles

• Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy  
  Audrey Sigmund, MD, Dove Press

Lectures

• Depth of response and progression free survival in CLL patients on ibrutinib. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018